Year 2014 / Volume 106 / Number 1
Puntos De Vista
The position of the Sociedad Española de Patología Digestiva on the current situation of hepatitis C management in Spain

46-50

Sociedad Española de Patología Digestiva

Abstract
The advent of direct-action antivirals telaprevir and boceprevir has entailed a radical change in the healing possibilities for patients with hepatitis C. This change has coincided with the emergence of highly robust evidence on the benefits of cure as regards increased overall survival, mainly brought about by a reduction in liver-related events in the long run. Therefore, a finite-in-time treatment is available that achieves very notable results both short- and long- term.
Triple therapy, consisting of the association of one of these novel drugs with the previously standard regimen of pegylated interferon and ribavirin, has come in the setting of a financial crisis, which has led to restrict its use primarily for patients with advanced fibrosis. These patients –who need a cure the most– are those with the lowest healing rates and the commonest, most severe side effects.
The time has then come to shift the aim point towards patients with less severe fibrosis, better cure rates, and fewer side effects where therapeutic intervention may prevent the development of significant liver disease.
Despite record-time approval by the European Medicines Agency, various barriers –mainly at the Autonomic regional level– have delayed access to these therapies by our patients, thus giving rise to inequality situations.
New oral therapies are now on the near horizon that will increase the numbers of patients eligible for treatment with fewer side effects and a higher cure rate. We hope that the lesson is learned and no such situation will be repeated. An Integrated National Action Plan Against Hepatitis C would be an essential tool for countering this disease.
Share Button
New comment
Comments

11/04/2014 14:51:56
Actualizacion del posicionamiento de la SEPD sobre la actual situacion del tratamiento de la hepatitis por virus C. Ver aquí: http://www.sepd.es/docs/ACTUALIZACION_POSICIONAMIENTO.pdf


Related articles
Citation tools
Sociedad Española de Patología Digestiva. The position of the Sociedad Española de Patología Digestiva on the current situation of hepatitis C management in Spain. 46-50


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 44 visits.
This article has been downloaded 33 times.
Share
This article has been rated by 2 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology